The New York law firm of Bernstein Liebhard LLP today announced that it has commenced an investigation of Schering-Plough Corporation (“Schering-Plough” or the “Company”) (NYSE: SGP) regarding the proposed merger pursuant to which Schering-Plough and Merck & Co., Inc. (“Merck”) (NYSE: MRK) will combine, under the name Merck, in a stock and cash transaction (the “Merger”).
Under the terms of the Merger, Schering-Plough shareholders will receive 0.5767 shares and $10.50 in cash for each share of Schering-Plough. Further, each Merck share will automatically become a share of the combined company. Upon closing of the transaction, Merck shareholders are expected to own approximately 68 percent of the combined company, and Schering-Plough shareholders are expected to own approximately 32 percent.
If you are a current holder of Schering-Plough and/or Merck shares and wish to discuss the above matter with us, or have any questions concerning your rights and interests as a shareholder of Schering-Plough and/or Merck with regard to the Merger, please contact the following: U. Seth Ottensoser of Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016 at (877) 779-1414 (toll free) or (212) 779-1414 or by email at ottensoser@bernlieb.com.
